SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-216942
Filing Date
2023-08-21
Accepted
2023-08-21 16:01:51
Documents
2
Group Members
BKB G2 INVESTMENTS, LLCBKB GROWTH INVESTMENTS, LLCPAUL B. MANNING REVOCABLE TRUST DATED MAY 10, 2000PBM 2023 GRANTOR RETAINED ANNUITY TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d510852dsc13da.htm SC 13D/A 108128
2 EXHIBIT A d510852dex99a.htm EX-99.A 7840
  Complete submission text file 0001193125-23-216942.txt   117466
Mailing Address 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA 22902
Business Address
Manning Paul B (Filed by) CIK: 0001494695 (see all company filings)

Type: SC 13D/A

Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Subject) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91724 | Film No.: 231189098
SIC: 2836 Biological Products, (No Diagnostic Substances)